Stereotactic radiosurgery of XXXX .

@entity5 @entity1 @entity5513 @entity2319
Stereotactic radiotherapy has an inherent disadvantage in that it does not directly reduce @entity5 volume. In this increasing environment of cost-containment, however, this modality offers several advantages (see box). Some investigators believe that, over the next generation, stereotactic radiotherapy will be the mainstay of @entity5513 care, with microsurgery being the exception and being reserved for @entity1 needing urgent decompression and for very young @entity1 [12]. Increasing numbers of @entity1 are undergoing stereotactic radiotherapy as a matter of preference following the provision of sufficient information on the two treatment procedures. When counseling younger @entity1 , it is important to remember that no long-term data about the control rate for stereotactic radiotherapy with the most recent, lower doses are available. Also, surgical salvage, which is necessary in some @entity1 , produces a poor outcome following radiation therapy. Published reports have demonstrated similar facial nerve, hearing preservation, and @entity5 control rates in the short term only [32,33]. Data is insufficient to assess the risk for inducing a secondary, treatment-related @entity5 . Until long-term results are available, stereotactic radiotherapy should be reserved for medically infirm @entity1 , elderly @entity1 , @entity1 with @entity2319 or @entity5 , and @entity1 who have failed prior microsurgery. Radiotherapy is not the preferred primary treatment modality for @entity5513 based on currently published results.
